Antidiabetic potential and enzyme kinetics of benzothiazole derivatives and their non-bonded interactions with α-glucosidase and α-amylase
作者:Ninad V. Puranik、Hemalata M. Puntambekar、Pratibha Srivastava
DOI:10.1007/s00044-016-1520-3
日期:2016.4
Benzothiazole derivatives were synthesized and their antidiabetic potential evaluated using α-glucosidase, α-amylase, non-enzymatic glycosylation of hemoglobin and advanced glycation end product inhibition assays. Compound 3l showed low IC50 values of 0.31, 0.98, 0.59 and 0.19 mM in α-amylase, α-glucosidase, non-enzymatic glycosylation of hemoglobin and AGE inhibition assays, respectively, and outperformed
合成了苯并噻唑衍生物,并使用α-葡萄糖苷酶,α-淀粉酶,血红蛋白的非酶糖基化和先进的糖化终产物抑制试验评估了它们的抗糖尿病潜力。化合物31在α-淀粉酶,α-葡萄糖苷酶,血红蛋白的非酶糖基化和AGE抑制试验中分别显示出0.31、0.98、0.59和0.19mM的低IC 50值,并且优于标准的阿卡波糖。酶动力学研究表明,α-淀粉酶和α-葡萄糖苷酶的K i分别为0.39和1.5 mM。3l的非键相互作用 用α-淀粉酶(3OLD)和α-葡萄糖苷酶(2ZE0)显示其结合在活性位点口袋中,并被3OLD中的残基Asp197,Glu233,Asp300和2ZE0中的Asp199,Glu256,Asp326包围。